نتایج جستجو برای: peripheral blood stem cell transplantation

تعداد نتایج: 2490817  

Journal: :Haematologica 2009
David Gallardo Rafael de la Cámara Jose B Nieto Ildefonso Espigado Arturo Iriondo Antonio Jiménez-Velasco Carlos Vallejo Carmen Martín Dolores Caballero Salut Brunet David Serrano Carlos Solano Josep M Ribera Javier de la Rubia Enric Carreras

BACKGROUND Granulocyte colony-stimulating factor mobilized peripheral blood stem cells are increasingly used instead of bone marrow as a stem cell source for transplantation. Whereas this change is almost complete for autologous transplantation, there are some concerns when considering allogeneic transplants. DESIGN AND METHODS We performed a retrospective case-control study including 820 adu...

Journal: :Turk pediatri arsivi 2014
Mehmet Akif Yeşilipek

Bone marrow transplantation is called hematopoetic stem cell transplantation (HSCT), since peripheral blood and umbilical cord blood can also be used as sources of stem cell currently. In children, bone marrow transplantation is used as a definite treatment method in many diseases including hemoglobinopaties, immune deficiencies, bone marrow failure and congenital metabolic diseases in addition...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran seyyedasadollah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran babak bahar hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran masoud iravani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hamdi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

post-remission treatment in patients with acute myeloid leukemia is still controversial. one potent choice for patients with no donor available is autologous stem cell transplantation. the median follow-up period was 18 months and the median age was 26 years old. in the review of 116 recently diagnosed aml patients (except aml- m3) who underwent autologous stem cell transplantation, 72.4% of pa...

Journal: :بینا 0
علیرضا برادران رفیعی ar baradaran-rafie ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم مهدی اصلانی m aslani ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم حسین حسن پور h hasanpoor ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم مرجان زارع جوشقانی m zare joshaghani ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم حسین جمالی h jamali دانشگاه علوم پزشکی شیراز محمد زارع جوشقانی m zare joshaghani ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم بهرام عین الهی

purpose: to report the outcomes of conjunctival-limbal autograft (clau) in patients with unilateral total limbal stem cell deficiency (lscd) emphasizing surgical problems, complications, and their management. methods: in this prospective interventional case series, clau combined with amniotic membrane transplantation as a graft was performed on 26 patients with unilateral total lscd due to chem...

Journal: :Japanese journal of clinical oncology 2002
Takashi Kobayashi Shingo Yamamoto Eijiro Nakamura Toshiyuki Kamato Yoshiyuki Kakehi Osamu Ogawa Noriyuki Ito Takuo Fukuyama Masakatsu Hishizawa Tatsuo Ichinohe

A variety of regimens of high-dose chemotherapy with hematopoietic stem cell support for poor risk germ cell tumors have been established. However, a series of chemotherapy steps carried out prior to the harvest sometimes leads to an insufficient number of peripheral blood stem cells. Here, we report a case of a patient who successfully underwent high-dose chemotherapy for the treatment of poor...

2010
C Zhang X-H Chen X Zhang L Gao P-Y Kong X-G Peng A-H Sun Y Gong D-F Zeng Q-Y Wang

Unmanipulated haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised peripheral blood stem cells (G-PBSCs) and granulocyte-colony stimulating factor-mobilised bone marrow (G-BM) has been developed as an alternative transplantation strategy for patients with haematologic malignancies. However, little information is available about the fact...

Journal: :international journal of pediatrics 0
saeed abroun department of hematology and blood banking, tarbiat modares university, tehran, iran.

stem cells are naïve or master cells. this means they can transform into special 200 cell types as needed by body, and each of these cells has just one function. stem cells are found in many parts of the human body, although some sources have richer concentrations than others. some excellent sources of stem cells, such as bone marrow, peripheral blood, cord blood, other tissue stem cells and hu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید